FLT3 and acute myeloid leukemia: Overall, this study provides new insights into the role of NOTCH signaling in response to TKI treatment and highlights CXCR3/ERK signaling as an alternative pathway of FLT3 inhibition, suggesting a combinational approach of TKI and GSI to treat FLT3/ITD+ AML.